Xspray Pharma’s Nomination Committee for the Annual General Meeting 2024
Regulatory press release 2023-10-24
Xspray Pharma AB (Nasdaq Stockholm: XSPRAY) publishes the Nomination Committee’s composition for the Annual General Meeting in 2024.
The Nomination Committee, which has been appointed in accordance with the principles adopted by the Annual General Meeting on 16 May 2023, consists of:
- Thomas Eldered, appointed by Flerie Invest AB
- Gillis Cullin, appointed by Östersjöstiftelsen
- Johan Gyllenswärd, appointed by Ribbskottet AB
- Jan Särlvik, appointed by AP4
- Anders Ekblom, Chairman of the Board of Directors, Xspray Pharma AB
The Nomination Committee shall, before the Annual General Meeting 2024, prepare proposals for the election of Chairman and other members of the Board of Directors, the election of Chairman of the Annual Meeting, election of auditors, the determination of fees and matters pertaining thereto.
Shareholders who wish to submit proposals to the Nomination Committee prior to the Annual General Meeting on May 21, 2024, can do so via e-mail to email@example.com before April 2, 2024.
For further information about the Nomination Committee, please contact:
Anders Ekblom, Chairman of the Board of Directors, Xspray Pharma AB